Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The Purpose of This Study is to Evaluate the Efficacy and Safety of Apafitini Combined With
PD1 in Patients With Advanced Gastric Cancer After Second-line Treatment Failure, Thus
Providing More Options for Patients With Advanced Gastric Cancer.